Overview

Effect of Pycnogenol® on ADHD

Status:
Completed
Trial end date:
2020-11-20
Target enrollment:
Participant gender:
Summary
This double blind, randomised controlled trial examines the effect of a commercially available nutritional supplement on behaviour of ADHD patients, as well as on their physical and psychiatric co-morbidities, and level of oxidative stress and immune activity, as compared to placebo and standard pharmaceutical treatment for ADHD.
Phase:
Phase 3
Details
Lead Sponsor:
Nina Hermans
Treatments:
Methylphenidate
Pycnogenols